# Neurology (neuromuscular) Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Lou Gehrig (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET018-SYN-TD
- Date: 1939-05-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gavin Hollister, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Priscilla Nakamura, MD, Neurology (neuromuscular)
- Urgency: Within two weeks

## Referral question

Progressive weakness and loss of coordination over about a year in a 35-year-old professional baseball player, with hand wasting, widespread fasciculations, weakness of grip and left ankle dorsiflexion, brisk reflexes with spread and Hoffmann signs, and normal sensation. I am concerned about a motor neuron disease. Please evaluate with EMG and nerve conduction studies, exclude treatable mimics, and advise on diagnosis and care. **S**

## Questions for the consultant

1. Does he have amyotrophic lateral sclerosis, or a treatable mimic such as cervical myelopathy, multifocal motor neuropathy, or an inflammatory or metabolic myopathy?
2. What do the EMG and nerve conduction studies show, and which diagnostic criteria are met?
3. What disease-modifying treatment do you advise, and should genetic testing be done?
4. How should breathing, nutrition, speech and swallowing, and mobility be monitored, and when should we intervene?
5. How should we support his work, his mood and early planning for future care?

## Pertinent history

About a year of gradually worsening weakness and clumsiness: a fall in his batting and fielding through last season, fumbling with buttons and the bat, tripping on curbs, a fall on the ice last winter, and cramps and twitching in the arms and thighs. Two days ago he took himself out of the lineup. No numbness, neck pain, double vision, ptosis, or trouble speaking, swallowing or breathing. Several concussions over his career, the last more than five years ago. Never smoked; one or two beers on some weekends. No medicines; no known allergies. Results today: blood count, sodium, potassium, creatinine, glucose and calcium normal; creatine kinase 412 U/L; vitamin B12 512 pg/mL; TSH 1.6 mIU/L; A1c 5.2%; ALT 32 U/L; seated FVC 4.62 L (90% of predicted). Serum protein electrophoresis with immunofixation and an HIV test sent; MRI of the brain and cervical spine booked for next week. He wants results given to him first, plainly. **S**

- Henry Louis Gehrig was born on June 19, 1903, in the Yorkville section of Manhattan, New York, to Heinrich and Christina Gehrig, German immigrants. **D**
- Three of his siblings died young: his sister Anna in September 1902 at about three months, his sister Sophie in the winter of 1906 of a combination of measles, diphtheria and bronchopneumonia, and a brother shortly after birth. **D**
- He enrolled at Columbia University on a football scholarship in February 1921. **D**
- He played first base for the New York Yankees and, on May 2, 1939, in Detroit, took himself out of the lineup after a then-record 2,130 consecutive games. **D**
- In 1938 he batted .295, the first time under .300 since 1925, and his hitting fell off sharply in midsummer; he had an attack of lumbago and a badly jammed thumb that season. In the winter of 1938 to 1939 he lost his strength and collapsed while ice skating, in spring training 1939 he collapsed while putting on his uniform pants and his reflexes had slowed alarmingly, and at 35 he batted .143 in the first games of the 1939 season. **D**
- His first neurological symptoms began in 1938, around the time of his 35th birthday. **D**
- He had repeated head injuries, including concussions, during his playing career. **D**

5 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: White cells: 6.8 10*3/uL; Hemoglobin: 15.2 g/dL; Platelets: 245 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 0.88 mg/dL; eGFR: 115 mL/min/1.73 m²; Glucose: 92 mg/dL; Calcium: 9.4 mg/dL; ALT: 32 U/L; AST: 30 U/L; Creatine kinase: 412 U/L (high); Vitamin B12: 512 pg/mL; TSH: 1.6 mIU/L; Hemoglobin A1c: 5.2%; Forced vital capacity (seated): 4.62 L; Forced vital capacity, percent predicted (seated): 90%; PHQ-2: 1. All results are synthetic.

BP 124/78 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 89.5 kg; BMI 26.7 kg/m². All vital signs are synthetic.

## Current medications

- No current medications. **S**

## Plan so far

- Evaluation of progressive weakness with mixed upper and lower motor neuron signs: blood count, metabolic panel with calcium, creatine kinase, vitamin B12, TSH, A1c, serum protein electrophoresis with immunofixation, and an HIV test; MRI of the brain and cervical spine; seated spirometry. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); A proposal for new diagnostic criteria for ALS (Gold Coast criteria) (2020); El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis (2000) **S**
- Safety while the evaluation proceeds: no competitive play or heavy lifting, a physical therapy assessment of balance and gait, home fall precautions (night lights, rails, no loose rugs), and a same-day call for any trouble swallowing or breathing; results given to him first, in person. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009) **S**
